Vensica hits milesones
Vensica hits its milesones with a successful phase IIa clinical trial and secures continued investment of $11M
Vensica has closed a $19 million
Vensica has closed a $19 million investment round to take the company through phase II. Learn more
Merz and Israeli start-up Vensica launch partnership
Merz and Israeli start-up Vensica launch partnership for needleless treatment of overactive bladder.Read more